Literature DB >> 35446554

Biosensing Extracellular Vesicle Subpopulations in Neurodegenerative Disease Conditions.

Yacine Mazouzi1, Fadoua Sallem1, Francesca Farina2, Alexis Loiseau1, Natayme Rocha Tartaglia2, Morgane Fontaine2, Atul Parikh1,3, Michèle Salmain4, Christian Neri2, Souhir Boujday1.   

Abstract

Extracellular vesicles (EVs) are secreted nanoparticles that are involved in intercellular communication and that modulate a wide range of biological processes in normal and disease conditions. However, EVs are highly heterogeneous in terms of origin in the cell, size, and density. As a result, complex protocols are required to identify and characterize specific EV subpopulations, limiting biomedical applications, notably in diagnostics. Here, we show that combining quartz crystal microbalance with dissipation (QCM-D) and nanoplasmonic sensing (NPS) provides a facile method to track the viscoelastic properties of small EVs. We applied this multisensing strategy to analyze small EVs isolated by differential ultracentrifugation from knock-in mouse striatal cells expressing either a mutated allele or wild-type allele of huntingtin (Htt), the Huntington's disease gene. Our results validate the sensing strategy coupling QCM-D and NPS and suggest that the mass and viscoelastic dissipation of EVs can serve as potent biomarkers for sensing the intercellular changes associated with the neurodegenerative condition.

Entities:  

Keywords:  extracellular vesicles; nano plasmonic sensing (NPS); neurodegenerative diseases; physical properties; quartz crystal microbalance with dissipation (QCM-D); subpopulations

Mesh:

Substances:

Year:  2022        PMID: 35446554     DOI: 10.1021/acssensors.1c02658

Source DB:  PubMed          Journal:  ACS Sens        ISSN: 2379-3694            Impact factor:   9.618


  1 in total

Review 1.  Diagnostic Approaches For COVID-19: Lessons Learned and the Path Forward.

Authors:  Maha Alafeef; Dipanjan Pan
Journal:  ACS Nano       Date:  2022-08-03       Impact factor: 18.027

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.